SRSF9 and ovarian carcinoma: For example, LARP1, an RNA binding protein in ovarian cancer, is a post-transcriptional regulator of survival and tumorigenesis (Hopkins et al., 2016); RNA binding proteins SRSF1 and SRSF9 can promote Wnt signaling-mediated tumorigenesis by enhancing β-catenin biosynthesis (Fu et al., 2013).